Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Ohio Health Research Institute / Riverside Methodist Hospital
mi
from
Columbus, OH
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Ohio Health Research Institute / Riverside Methodist Hospital
mi
from
Columbus, OH
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Heritage Valley Health System
mi
from
Beaver, PA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Heritage Valley Health System
mi
from
Beaver, PA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Cardiology Consultants or Mainline Health System
mi
from
Bryn Mawr, PA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Cardiology Consultants or Mainline Health System
mi
from
Bryn Mawr, PA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Moffitt Heart and Vascular Group
mi
from
Wormleysburg, PA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Moffitt Heart and Vascular Group
mi
from
Wormleysburg, PA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
The Miriam Hospital Weight Control and Diabetes Research Center
mi
from
Providence, RI
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
The Miriam Hospital Weight Control and Diabetes Research Center
mi
from
Providence, RI
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Greenville Hospital System Univeristy Medical Center
mi
from
Greenville, SC
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Greenville Hospital System Univeristy Medical Center
mi
from
Greenville, SC
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Wellmont Holston Valley Medical Center
mi
from
Kingsport, TN
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Wellmont Holston Valley Medical Center
mi
from
Kingsport, TN
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Vanderiblt University Medical Center
mi
from
Nashville, TN
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Vanderiblt University Medical Center
mi
from
Nashville, TN
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Alice Heart Center
mi
from
Alice, TX
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Alice Heart Center
mi
from
Alice, TX
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Austin Heart Hospital
mi
from
Austin, TX
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Austin Heart Hospital
mi
from
Austin, TX
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Cardiovascular Specialist of Texas & North Austin Medical Center
mi
from
Austin, TX
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Cardiovascular Specialist of Texas & North Austin Medical Center
mi
from
Austin, TX
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Cardiovascular Research Institute of Dallas
mi
from
Dallas, TX
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Cardiovascular Research Institute of Dallas
mi
from
Dallas, TX
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Plaza Medical Center of Fort Worth
mi
from
Fort Worth, TX
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Plaza Medical Center of Fort Worth
mi
from
Fort Worth, TX
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
North Cascade Cardiology
mi
from
Bellingham, WA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
North Cascade Cardiology
mi
from
Bellingham, WA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Columbia-Saint Mary's Cancer Care Center
mi
from
Milwaukee, WI
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Columbia-Saint Mary's Cancer Care Center
mi
from
Milwaukee, WI
CT Coronary Angiogram Versus Traditional Care in Emergency Department Assessment of Potential ACS
Randomized Controlled Study of a Rapid "Rule Out" Strategy Using CT Coronary Angiogram Versus Traditional Care for Low- to Intermediate-Risk ED Patients With Potential Acute Coronary Syndromes
Status: Archived
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
CT Coronary Angiogram Versus Traditional Care in Emergency Department Assessment of Potential ACS
Randomized Controlled Study of a Rapid "Rule Out" Strategy Using CT Coronary Angiogram Versus Traditional Care for Low- to Intermediate-Risk ED Patients With Potential Acute Coronary Syndromes
Status: Archived
Updated: 1/1/1970
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
CT Coronary Angiogram Versus Traditional Care in Emergency Department Assessment of Potential ACS
Randomized Controlled Study of a Rapid "Rule Out" Strategy Using CT Coronary Angiogram Versus Traditional Care for Low- to Intermediate-Risk ED Patients With Potential Acute Coronary Syndromes
Status: Archived
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
CT Coronary Angiogram Versus Traditional Care in Emergency Department Assessment of Potential ACS
Randomized Controlled Study of a Rapid "Rule Out" Strategy Using CT Coronary Angiogram Versus Traditional Care for Low- to Intermediate-Risk ED Patients With Potential Acute Coronary Syndromes
Status: Archived
Updated: 1/1/1970
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
CT Coronary Angiogram Versus Traditional Care in Emergency Department Assessment of Potential ACS
Randomized Controlled Study of a Rapid "Rule Out" Strategy Using CT Coronary Angiogram Versus Traditional Care for Low- to Intermediate-Risk ED Patients With Potential Acute Coronary Syndromes
Status: Archived
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
CT Coronary Angiogram Versus Traditional Care in Emergency Department Assessment of Potential ACS
Randomized Controlled Study of a Rapid "Rule Out" Strategy Using CT Coronary Angiogram Versus Traditional Care for Low- to Intermediate-Risk ED Patients With Potential Acute Coronary Syndromes
Status: Archived
Updated: 1/1/1970
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
CT Coronary Angiogram Versus Traditional Care in Emergency Department Assessment of Potential ACS
Randomized Controlled Study of a Rapid "Rule Out" Strategy Using CT Coronary Angiogram Versus Traditional Care for Low- to Intermediate-Risk ED Patients With Potential Acute Coronary Syndromes
Status: Archived
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
CT Coronary Angiogram Versus Traditional Care in Emergency Department Assessment of Potential ACS
Randomized Controlled Study of a Rapid "Rule Out" Strategy Using CT Coronary Angiogram Versus Traditional Care for Low- to Intermediate-Risk ED Patients With Potential Acute Coronary Syndromes
Status: Archived
Updated: 1/1/1970
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Beef in an Optimal Lean Diet (BOLD) Effects on Metabolic Syndrome
BOLD (Beef in an Optimal Lean Diet) Effects on Established and Emerging Cardiovascular Disease (CVD) Risk Factors: Effects on Metabolic Syndrome (BOLD-X)
Status: Archived
Penn State University
mi
from
Hershey, PA
Beef in an Optimal Lean Diet (BOLD) Effects on Metabolic Syndrome
BOLD (Beef in an Optimal Lean Diet) Effects on Established and Emerging Cardiovascular Disease (CVD) Risk Factors: Effects on Metabolic Syndrome (BOLD-X)
Status: Archived
Updated: 1/1/1970
Penn State University
mi
from
Hershey, PA
Study of Non-Invasive Regional Oxygen Saturations in Pediatric Patients Undergoing Cardiac Catheterization
Calibration and Validation of the a Non-Invasive Regional Oxygen Saturation Device in Neonates, Infants and Children Undergoing Cardiac Catheterization
Status: Archived
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Study of Non-Invasive Regional Oxygen Saturations in Pediatric Patients Undergoing Cardiac Catheterization
Calibration and Validation of the a Non-Invasive Regional Oxygen Saturation Device in Neonates, Infants and Children Undergoing Cardiac Catheterization
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Study of Non-Invasive Regional Oxygen Saturations in Pediatric Patients Undergoing Cardiac Catheterization
Calibration and Validation of the a Non-Invasive Regional Oxygen Saturation Device in Neonates, Infants and Children Undergoing Cardiac Catheterization
Status: Archived
Rush University Medical Center
mi
from
Chicago, IL
Study of Non-Invasive Regional Oxygen Saturations in Pediatric Patients Undergoing Cardiac Catheterization
Calibration and Validation of the a Non-Invasive Regional Oxygen Saturation Device in Neonates, Infants and Children Undergoing Cardiac Catheterization
Status: Archived
Updated: 1/1/1970
Rush University Medical Center
mi
from
Chicago, IL
Study of Non-Invasive Regional Oxygen Saturations in Pediatric Patients Undergoing Cardiac Catheterization
Calibration and Validation of the a Non-Invasive Regional Oxygen Saturation Device in Neonates, Infants and Children Undergoing Cardiac Catheterization
Status: Archived
Children's Hospital Central California
mi
from
Madera, CA
Study of Non-Invasive Regional Oxygen Saturations in Pediatric Patients Undergoing Cardiac Catheterization
Calibration and Validation of the a Non-Invasive Regional Oxygen Saturation Device in Neonates, Infants and Children Undergoing Cardiac Catheterization
Status: Archived
Updated: 1/1/1970
Children's Hospital Central California
mi
from
Madera, CA
Impact of Statins on Cytokine Expression in Pneumonia
Impact of Statins on Cytokine Expression in Pneumonia
Status: Archived
Audie L Murphy Veterans Administration Hospital
mi
from
San Antonio, TX
Impact of Statins on Cytokine Expression in Pneumonia
Impact of Statins on Cytokine Expression in Pneumonia
Status: Archived
Updated: 1/1/1970
Audie L Murphy Veterans Administration Hospital
mi
from
San Antonio, TX
Support for Cardiovascular Health in African American Primary Care Patients
Peer and Health Educator Support for Cardiovascular Health in African-American Primary Care Patients
Status: Archived
Edward S. Cooper Practice of General Internal Medicine
mi
from
Philadelphia, PA
Support for Cardiovascular Health in African American Primary Care Patients
Peer and Health Educator Support for Cardiovascular Health in African-American Primary Care Patients
Status: Archived
Updated: 1/1/1970
Edward S. Cooper Practice of General Internal Medicine
mi
from
Philadelphia, PA
Support for Cardiovascular Health in African American Primary Care Patients
Peer and Health Educator Support for Cardiovascular Health in African-American Primary Care Patients
Status: Archived
Pennington Biodmedical Research
mi
from
Baton Rouge, LA
Support for Cardiovascular Health in African American Primary Care Patients
Peer and Health Educator Support for Cardiovascular Health in African-American Primary Care Patients
Status: Archived
Updated: 1/1/1970
Pennington Biodmedical Research
mi
from
Baton Rouge, LA
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
University of Alabama at Birmingham
mi
from
Birmingham, AL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
University of Alabama at Birmingham
mi
from
Birmingham, AL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
North Phoenix Heart Center
mi
from
Phoenix, AZ
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
North Phoenix Heart Center
mi
from
Phoenix, AZ
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Heart & Vascular Center of Arizona
mi
from
Phoenix, AZ
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Heart & Vascular Center of Arizona
mi
from
Phoenix, AZ
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Cardiology and Medicine Clinic, PA
mi
from
Little Rock, AR
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Cardiology and Medicine Clinic, PA
mi
from
Little Rock, AR
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Grossmont Center for Clinical Research
mi
from
La Mesa, CA
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Grossmont Center for Clinical Research
mi
from
La Mesa, CA
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Mission Internal Medical Group
mi
from
Mission Viejo, CA
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Mission Internal Medical Group
mi
from
Mission Viejo, CA
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Sutter Roseville Medical Center
mi
from
Roseville, CA
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Sutter Roseville Medical Center
mi
from
Roseville, CA
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Sacramento Heart & Vascular Research Center
mi
from
Sacramento, CA
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Sacramento Heart & Vascular Research Center
mi
from
Sacramento, CA
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Santa Rosa Cardiology Medical Group, Inc.
mi
from
Santa Rosa, CA
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Santa Rosa Cardiology Medical Group, Inc.
mi
from
Santa Rosa, CA
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Cardiovascular Consultants Medical Group
mi
from
Walnut Creek, CA
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Cardiovascular Consultants Medical Group
mi
from
Walnut Creek, CA
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Center for Fertility and Women's Health
mi
from
New Britain, CT
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Center for Fertility and Women's Health
mi
from
New Britain, CT
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Alfieri Cardiology
mi
from
Newark, DE
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Alfieri Cardiology
mi
from
Newark, DE
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Daytona Heart Group
mi
from
Daytona Beach, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Daytona Heart Group
mi
from
Daytona Beach, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Cardiology Associates of Gainesville
mi
from
Gainesville, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Cardiology Associates of Gainesville
mi
from
Gainesville, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
University of Florida Health Science Center - Jacksonville
mi
from
Jacksonville, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
University of Florida Health Science Center - Jacksonville
mi
from
Jacksonville, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Jacksonville Heart Center, P.A.
mi
from
Jacksonville, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Jacksonville Heart Center, P.A.
mi
from
Jacksonville, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Jacksonville Heart Center
mi
from
Jacksonville, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Jacksonville Heart Center
mi
from
Jacksonville, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
mi
from
St Louis, MO
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
mi
from
St Louis, MO
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Jacksonville Cardiovascular Center
mi
from
Jacksonville, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Jacksonville Cardiovascular Center
mi
from
Jacksonville, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Melbourne Internal Medical Associates
mi
from
Melbourne, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Melbourne Internal Medical Associates
mi
from
Melbourne, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Cardiovascular Center of South Florida
mi
from
Miami, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Cardiovascular Center of South Florida
mi
from
Miami, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Collier Health Management Associates Physician Management Incorporated
mi
from
Naples, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Collier Health Management Associates Physician Management Incorporated
mi
from
Naples, FL
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Med College of Georgia
mi
from
Augusta, GA
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Status: Archived
Updated: 1/1/1970
Med College of Georgia
mi
from
Augusta, GA